BG101431A - the 2-(3,5-DIFLUOROPHENYL)-3-(4-(METHYLSULPHONYL)PHENYL-2-CYLOPENTEN-1 -ON APPLICABLE AS COX-2 INHIBITOR - Google Patents

the 2-(3,5-DIFLUOROPHENYL)-3-(4-(METHYLSULPHONYL)PHENYL-2-CYLOPENTEN-1 -ON APPLICABLE AS COX-2 INHIBITOR

Info

Publication number
BG101431A
BG101431A BG101431A BG10143197A BG101431A BG 101431 A BG101431 A BG 101431A BG 101431 A BG101431 A BG 101431A BG 10143197 A BG10143197 A BG 10143197A BG 101431 A BG101431 A BG 101431A
Authority
BG
Bulgaria
Prior art keywords
cox
cylopenten
methylsulphonyl
difluorophenyl
inhibitor
Prior art date
Application number
BG101431A
Other languages
Bulgarian (bg)
Inventor
Cameron Black
Original Assignee
Merck Frosst Canada Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Frosst Canada Inc. filed Critical Merck Frosst Canada Inc.
Priority to BG101431A priority Critical patent/BG101431A/en
Publication of BG101431A publication Critical patent/BG101431A/en

Links

Abstract

The compound has the formulaThe invention also relates to pharmaceutical compositions of theabove compound and to its utilization for the preparation ofmedicamentous forms for the treatment of deseases mediated bycyclooxygenase-2 (COX-2).30 claims
BG101431A 1997-04-22 1997-04-22 the 2-(3,5-DIFLUOROPHENYL)-3-(4-(METHYLSULPHONYL)PHENYL-2-CYLOPENTEN-1 -ON APPLICABLE AS COX-2 INHIBITOR BG101431A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
BG101431A BG101431A (en) 1997-04-22 1997-04-22 the 2-(3,5-DIFLUOROPHENYL)-3-(4-(METHYLSULPHONYL)PHENYL-2-CYLOPENTEN-1 -ON APPLICABLE AS COX-2 INHIBITOR

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BG101431A BG101431A (en) 1997-04-22 1997-04-22 the 2-(3,5-DIFLUOROPHENYL)-3-(4-(METHYLSULPHONYL)PHENYL-2-CYLOPENTEN-1 -ON APPLICABLE AS COX-2 INHIBITOR

Publications (1)

Publication Number Publication Date
BG101431A true BG101431A (en) 1999-03-31

Family

ID=3926979

Family Applications (1)

Application Number Title Priority Date Filing Date
BG101431A BG101431A (en) 1997-04-22 1997-04-22 the 2-(3,5-DIFLUOROPHENYL)-3-(4-(METHYLSULPHONYL)PHENYL-2-CYLOPENTEN-1 -ON APPLICABLE AS COX-2 INHIBITOR

Country Status (1)

Country Link
BG (1) BG101431A (en)

Similar Documents

Publication Publication Date Title
AP9901478A0 (en) Compounds for the treatment of ischemia.
PL326203A1 (en) (methylsulphonyl)phenyl-2-(5)-furanones as cox-2 inhibitors
MY133996A (en) Compounds for the treatment of ischemia
PT966465E (en) IMFDH ENZYME INHIBITORS
PL327735A1 (en) Novel substituted derivatives of imidazole
PT935465E (en) NEW IMIDAZOLE REPLACED COMPOUNDS
BG104315A (en) Prostaglandine agonists and their application for the treatment of osteal diseases
EP1385508A4 (en) Dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
MXPA03010961A (en) Thiazole compounds useful as inhibitors of protein kinases.
IE840302L (en) 3-(5-aminopentyl)amino-1-benzazepin-2-one-1-alkanoic acids.
IL164568A0 (en) Compounds and methods for the inhibition of the expression of vcam-1
ES2136037A1 (en) Sulfamide-metalloprotease inhibitors
HUP0102250A3 (en) Compounds of unstable dipeptidyl peptidase iv inhibitors, pharmaceutical compositions comprising thereof and their use
YU9802A (en) Cell adhesion inhibitors
MX9702070A (en) New osseous resorption inhibitors and vitronectine receptor antagonists.
EP0911321A3 (en) Compounds for the treatment of osteoporosis
TR200103216T2 (en) Pyrimidinone compositions
DE69905476D1 (en) Phosphonsaürederivate als ptp-1b-inhibitoren
ATE212343T1 (en) 3,4-DIARYL-2-HYDROXY-2,5-DIHYDROFURANES AS PRECURSORS OF COX-2 INHIBITORS
HK1028568A1 (en) Alpha-ketoamide multicatalytic protease inhibitors
UA50808C2 (en) Composition for treatment of irds and ards
BG105256A (en) Muscarinic agonists and antagonists
ZA986673B (en) Use of a combination of an inhibitor of converting enzyme and a diuretic for treating microcirculatory disorders
EP0726072A3 (en) Composition for the treatment of hypertension and congestive heart failure, containing an angiotensin II antagonist and an endopeptidase inhibitor
TR200201128T2 (en) Tetrahydrothiopyraniphalazinone derivatives as PDE4 inhibitors.